SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID

SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID was reported 726 times

SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PES ANSERINUS SYNDROME 1 0.3333
1 IMAGING PROCEDURE ARTIFACT 3 0.1875
2 POSTPOLYPECTOMY SYNDROME 1 0.1667
3 OCCUPATIONAL EXPOSURE TO SUNLIGHT 1 0.0769
4 OOCYTE HARVEST 1 0.0526
5 LYMPHOID HYPERPLASIA OF INTESTINE 1 0.0455
6 FIXED BOWEL LOOP 1 0.0370
7 OCCUPATIONAL EXPOSURE TO RADIATION 1 0.0286
8 PROCEDURE ABORTED 1 0.0286
9 JOINT DEFORMITY 2 0.0267
10 BLOOD GLUCOSE NORMAL 1 0.0250
11 INCISION SITE ULCER 1 0.0208
12 MAGNESIUM METABOLISM DISORDER 1 0.0204
13 MESENTERIC LYMPHADENITIS 1 0.0192
14 CLAUDICATION OF JAW MUSCLES 1 0.0167
15 DENTAL PARAESTHESIA 1 0.0164
16 PRODUCT PACKAGING DIFFICULT TO OPEN 35 0.0134
17 THERAPEUTIC PRODUCT EFFECT PROLONGED 5 0.0110
18 IRON BINDING CAPACITY TOTAL INCREASED 1 0.0108
19 ILEOCOLECTOMY 1 0.0100
20 SALPINGO-OOPHORECTOMY BILATERAL 2 0.0099
21 INTESTINAL CONGESTION 1 0.0096
22 ADHESIOLYSIS 1 0.0093
23 ANAL ERYTHEMA 1 0.0080
24 GASTROINTESTINAL LYMPHOMA 2 0.0077
25 FISTULA OF SMALL INTESTINE 3 0.0072
26 MESENTERIC PANNICULITIS 2 0.0067
27 ADNEXA UTERI CYST 1 0.0062
28 ARTHRITIS ENTEROPATHIC 2 0.0061
29 THYROGLOBULIN INCREASED 1 0.0059
30 POSTPRANDIAL HYPOGLYCAEMIA 1 0.0053
31 DEAFNESS PERMANENT 1 0.0051
32 TERMINAL ILEITIS 3 0.0049
33 GREATER TROCHANTERIC PAIN SYNDROME 1 0.0049
34 SALT CRAVING 1 0.0048
35 PRODUCT INTOLERANCE 1 0.0045
36 NEUROGENIC BOWEL 1 0.0042
37 SALPINGECTOMY 2 0.0035
38 BURSA DISORDER 1 0.0034
39 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
40 WRONG SCHEDULE 3 0.0031
41 HYPERCHLORAEMIA 2 0.0031
42 ILEECTOMY 1 0.0030
43 ANASTOMOTIC COMPLICATION 1 0.0029
44 PERINEAL PAIN 2 0.0028
45 LABELLED DRUG-DRUG INTERACTION ISSUE 4 0.0028
46 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
47 MIXED ANXIETY AND DEPRESSIVE DISORDER 1 0.0027
48 LID SULCUS DEEPENED 1 0.0027
49 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
50 PRODUCT TASTE ABNORMAL 34 0.0025
51 CLUBBING 1 0.0025
52 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1 0.0023
53 ABDOMINAL LYMPHADENOPATHY 2 0.0023
54 FUNGAL FOOT INFECTION 1 0.0023
55 ANASTOMOTIC ULCER 1 0.0022
56 PRODUCT AFTER TASTE 2 0.0021
57 INJECTION SITE NECROSIS 4 0.0020
58 PROCEDURAL SITE REACTION 1 0.0019
59 BLADDER DILATATION 2 0.0018
60 GASTROINTESTINAL TRACT IRRITATION 2 0.0018
61 COLON INJURY 1 0.0017
62 PROTRUSION TONGUE 1 0.0017
63 PERNICIOUS ANAEMIA 1 0.0016
64 INTESTINAL ANASTOMOSIS 1 0.0016
65 SMALL INTESTINE ULCER 1 0.0015
66 GASTROINTESTINAL MUCOSAL DISORDER 1 0.0015
67 WISDOM TEETH REMOVAL 2 0.0015
68 ANORECTAL DISCOMFORT 8 0.0015
69 OPHTHALMIC MIGRAINE 1 0.0014
70 GASTROINTESTINAL SCARRING 1 0.0014
71 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
72 GASTROINTESTINAL WALL THICKENING 2 0.0013
73 POLYPECTOMY 1 0.0013
74 VERTEBRAL FORAMINAL STENOSIS 1 0.0012
75 GASTROENTERITIS SALMONELLA 1 0.0012
76 PERIORBITAL PAIN 1 0.0012
77 NUCHAL RIGIDITY 1 0.0011
78 BONE GRAFT 1 0.0011
79 BONE CYST 1 0.0011
80 PRODUCT USE COMPLAINT 16 0.0010
81 HYPERAEMIA 2 0.0010
82 SPUTUM RETENTION 1 0.0010
83 BLADDER CANCER RECURRENT 1 0.0010
84 HAEMANGIOMA OF LIVER 1 0.0010
85 MUCOSAL ULCERATION 1 0.0010
86 ILEAL ULCER 1 0.0010
87 EYELID PAIN 2 0.0010
88 DYSAESTHESIA 3 0.0010
89 DUODENITIS 3 0.0010
90 CHANGE OF BOWEL HABIT 2 0.0010
91 PHARYNGEAL ERYTHEMA 2 0.0009
92 PROCTALGIA 6 0.0009
93 CARBON DIOXIDE DECREASED 1 0.0009
94 CHEMICAL BURN 1 0.0009
95 MUCOSAL HAEMORRHAGE 1 0.0009
96 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
97 INCISION SITE PAIN 1 0.0009
98 HYPERTENSIVE EMERGENCY 1 0.0008
99 LARGE INTESTINE INFECTION 1 0.0008
100 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
101 BLOOD UREA DECREASED 1 0.0008
102 ABNORMAL UTERINE BLEEDING 2 0.0008
103 ELECTROLYTE IMBALANCE 9 0.0008
104 LIP INJURY 1 0.0008
105 RETCHING 16 0.0007
106 INTESTINAL DILATATION 1 0.0007
107 AGORAPHOBIA 1 0.0007
108 CHRONIC FATIGUE SYNDROME 1 0.0007
109 THERAPEUTIC RESPONSE DELAYED 2 0.0007
110 TONGUE DISCOMFORT 3 0.0007
111 AUDITORY DISORDER 1 0.0007
112 GLUTEN SENSITIVITY 1 0.0007
113 PRODUCT LABEL CONFUSION 4 0.0007
114 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
115 PRECANCEROUS SKIN LESION 1 0.0007
116 ANAL INCONTINENCE 6 0.0007
117 ORAL MUCOSAL EXFOLIATION 1 0.0007
118 EMBOLISM VENOUS 2 0.0007
119 ABDOMINAL HERNIA 3 0.0007
120 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
121 PHARYNGEAL PARAESTHESIA 1 0.0006
122 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
123 TONGUE ULCERATION 2 0.0006
124 ENTERITIS INFECTIOUS 1 0.0006
125 TONGUE COATED 1 0.0006
126 ORAL DISCOMFORT 8 0.0006
127 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
128 VERTIGO POSITIONAL 1 0.0006
129 GASTROINTESTINAL OEDEMA 1 0.0006
130 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
131 OESOPHAGEAL SPASM 1 0.0005
132 COLECTOMY 3 0.0005
133 SACROILIITIS 1 0.0005
134 MYELOPATHY 1 0.0005
135 GALLBLADDER INJURY 1 0.0005
136 CARDIAC DISCOMFORT 1 0.0005
137 SLEEP DEFICIT 1 0.0005
138 LYMPHOCYTOSIS 1 0.0005
139 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 33 0.0005
140 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
141 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
142 IMPLANT SITE INFECTION 1 0.0004
143 MENOPAUSAL SYMPTOMS 1 0.0004
144 VOLVULUS 1 0.0004
145 MYOPIA 1 0.0004
146 FAECES DISCOLOURED 9 0.0004
147 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
148 UTERINE LEIOMYOMA 3 0.0004
149 ABDOMINAL TENDERNESS 2 0.0004
150 BLOOD CHLORIDE DECREASED 1 0.0004
151 BLOOD LACTIC ACID INCREASED 2 0.0004
152 PRODUCT PRESCRIBING ERROR 9 0.0004
153 FREQUENT BOWEL MOVEMENTS 10 0.0004
154 GASTRIC PERFORATION 1 0.0004
155 ABNORMAL FAECES 3 0.0004
156 ANAL HAEMORRHAGE 1 0.0004
157 PROCTITIS 1 0.0004
158 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
159 VOMITING PROJECTILE 1 0.0003
160 THERAPEUTIC REACTION TIME DECREASED 1 0.0003
161 SPINAL OSTEOARTHRITIS 3 0.0003
162 REBOUND ACID HYPERSECRETION 1 0.0003
163 DYSCHEZIA 1 0.0003
164 FIBROSIS 1 0.0003
165 ABDOMINAL PAIN LOWER 8 0.0003
166 FAECAL CALPROTECTIN INCREASED 1 0.0003
167 EXPOSURE TO TOXIC AGENT 1 0.0003
168 ENTERITIS 2 0.0003
169 THROAT IRRITATION 14 0.0003
170 TREATMENT NONCOMPLIANCE 17 0.0003
171 LOOSE TOOTH 1 0.0003
172 HEART RATE IRREGULAR 7 0.0003
173 FACET JOINT SYNDROME 1 0.0003
174 INJECTION SITE INFECTION 1 0.0003
175 ADVERSE REACTION 4 0.0003
176 PEPTIC ULCER 1 0.0003
177 METASTASES TO SPINE 1 0.0003
178 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
179 WOUND DEHISCENCE 1 0.0003
180 REGURGITATION 1 0.0003
181 COLITIS 11 0.0003
182 EAR PRURITUS 1 0.0003
183 COLD SWEAT 5 0.0003
184 THIRST 5 0.0003
185 ABDOMINAL DISTENSION 29 0.0003
186 SKIN LACERATION 3 0.0003
187 FAECES SOFT 2 0.0003
188 THROAT CLEARING 1 0.0003
189 BLOOD SODIUM DECREASED 5 0.0003
190 AUTOIMMUNE THYROIDITIS 1 0.0003
191 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
192 FACE INJURY 1 0.0003
193 BOWEL MOVEMENT IRREGULARITY 2 0.0003
194 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
195 HYPOALBUMINAEMIA 2 0.0003
196 WOUND SECRETION 1 0.0003
197 GASTROINTESTINAL INFLAMMATION 2 0.0003
198 FRUSTRATION TOLERANCE DECREASED 2 0.0002
199 GALLBLADDER OPERATION 1 0.0002
200 DISCOMFORT 15 0.0002
201 INCORRECT DOSE ADMINISTERED 56 0.0002
202 TENSION HEADACHE 1 0.0002
203 HYSTERECTOMY 2 0.0002
204 TOOTH INJURY 1 0.0002
205 MELANOCYTIC NAEVUS 1 0.0002
206 PRODUCT COMMUNICATION ISSUE 2 0.0002
207 PHYSICAL DISABILITY 1 0.0002
208 RHINITIS ALLERGIC 1 0.0002
209 IRON DEFICIENCY 1 0.0002
210 VASCULAR DEVICE INFECTION 1 0.0002
211 PERIPHERAL COLDNESS 3 0.0002
212 DYSPAREUNIA 1 0.0002
213 UROSEPSIS 2 0.0002
214 SYNOVIAL CYST 1 0.0002
215 NEPHROGENIC ANAEMIA 1 0.0002
216 ARTHRITIS INFECTIVE 1 0.0002
217 HYPOMAGNESAEMIA 3 0.0002
218 IMPAIRED QUALITY OF LIFE 3 0.0002
219 PRESYNCOPE 5 0.0002
220 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
221 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
222 OVARIAN CYST 2 0.0002
223 FLUID INTAKE REDUCED 1 0.0002
224 DEHYDRATION 26 0.0002
225 VOMITING 91 0.0002
226 SKIN NECROSIS 1 0.0002
227 TENDERNESS 2 0.0002
228 SERUM FERRITIN INCREASED 1 0.0002
229 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
230 INTESTINAL RESECTION 1 0.0002
231 OSTEONECROSIS 6 0.0002
232 CHOKING SENSATION 1 0.0002
233 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
234 FEELING COLD 5 0.0002
235 HERPES VIRUS INFECTION 1 0.0002
236 ENTEROCOLITIS 1 0.0002
237 HYPOVOLAEMIA 1 0.0002
238 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
239 WRIST FRACTURE 2 0.0002
240 END STAGE RENAL DISEASE 3 0.0002
241 UNDERDOSE 12 0.0002
242 VULVOVAGINAL BURNING SENSATION 1 0.0002
243 RESPIRATORY DEPRESSION 2 0.0002
244 MENISCUS INJURY 1 0.0002
245 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
246 OLIGURIA 1 0.0002
247 PHOTOPHOBIA 3 0.0002
248 BLEPHAROSPASM 1 0.0002
249 FLATULENCE 9 0.0002
250 PRODUCT COMPLAINT 4 0.0002
251 FOREIGN BODY SENSATION IN EYES 1 0.0002
252 SKIN ULCER 4 0.0002
253 CARDIAC FLUTTER 1 0.0002
254 DYSPEPSIA 15 0.0002
255 PRODUCT PREPARATION ISSUE 1 0.0002
256 BEDRIDDEN 2 0.0002
257 HYPOKALAEMIA 7 0.0002
258 PRODUCT FORMULATION ISSUE 1 0.0002
259 DRUG INEFFECTIVE 196 0.0001
260 COLITIS ISCHAEMIC 1 0.0001
261 SINUS CONGESTION 2 0.0001
262 EYE MOVEMENT DISORDER 1 0.0001
263 ONYCHOCLASIS 1 0.0001
264 DROOLING 1 0.0001
265 BLOOD PRESSURE INCREASED 22 0.0001
266 PAPULE 1 0.0001
267 THERMAL BURN 1 0.0001
268 PRODUCT STORAGE ERROR 12 0.0001
269 ORAL DISORDER 1 0.0001
270 NAUSEA 107 0.0001
271 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
272 ECONOMIC PROBLEM 2 0.0001
273 THERAPEUTIC RESPONSE DECREASED 8 0.0001
274 ABDOMINAL PAIN UPPER 27 0.0001
275 LIPASE INCREASED 1 0.0001
276 ILLNESS 13 0.0001
277 BLOOD ALBUMIN DECREASED 1 0.0001
278 RENAL CYST 1 0.0001
279 ULCER 2 0.0001
280 ABSCESS 2 0.0001
281 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
282 SENSORY LOSS 1 0.0001
283 MYASTHENIA GRAVIS 1 0.0001
284 POST PROCEDURAL INFECTION 1 0.0001
285 SECOND PRIMARY MALIGNANCY 1 0.0001
286 HEMIPLEGIA 1 0.0001
287 VIRAL INFECTION 4 0.0001
288 URINARY RETENTION 4 0.0001
289 PRODUCT CONTAINER ISSUE 1 0.0001
290 SKIN HYPERPIGMENTATION 1 0.0001
291 MUSCLE STRAIN 1 0.0001
292 SKIN SWELLING 1 0.0001
293 NAIL DISORDER 1 0.0001
294 GASTRITIS 3 0.0001
295 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
296 LYMPHADENOPATHY 4 0.0001
297 RESPIRATORY RATE INCREASED 1 0.0001
298 OROPHARYNGEAL DISCOMFORT 1 0.0001
299 LIMB INJURY 3 0.0001
300 PELVIC PAIN 2 0.0001
301 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
302 PROCEDURAL PAIN 3 0.0001
303 CONJUNCTIVITIS 2 0.0001
304 LACERATION 1 0.0001
305 INTESTINAL OBSTRUCTION 4 0.0001
306 ARRHYTHMIA 5 0.0001
307 HAEMORRHOIDS 2 0.0001
308 TREMOR 17 0.0001
309 CHILLS 12 0.0001
310 HEPATOMEGALY 1 0.0001
311 BODY TEMPERATURE DECREASED 1 0.0001
312 BLOOD POTASSIUM DECREASED 3 0.0001
313 BRAIN INJURY 1 0.0001
314 PRODUCT ADMINISTRATION ERROR 2 0.0001
315 VAGINAL DISCHARGE 1 0.0001
316 HYPOTHERMIA 1 0.0001
317 DRY THROAT 1 0.0001
318 BODY TEMPERATURE INCREASED 2 0.0001
319 EAR DISCOMFORT 1 0.0001
320 HYPERBILIRUBINAEMIA 1 0.0001
321 VENTRICULAR EXTRASYSTOLES 1 0.0001
322 DIARRHOEA 62 0.0001
323 INJECTION SITE DISCOMFORT 1 0.0001
324 INCONTINENCE 1 0.0001
325 JOINT INJURY 2 0.0001
326 MOVEMENT DISORDER 3 0.0001
327 DECREASED ACTIVITY 1 0.0001
328 MUSCLE SPASMS 17 0.0001
329 ASPIRATION 1 0.0001
330 BLOOD GLUCOSE FLUCTUATION 1 0.0001
331 PRODUCT USE ISSUE 17 0.0001
332 ABDOMINAL PAIN 21 0.0001
333 GAIT INABILITY 3 0.0001
334 ORAL PAIN 2 0.0001
335 SNEEZING 2 0.0001
336 CHROMATURIA 2 0.0001
337 SCAB 1 0.0001
338 CHOLECYSTECTOMY 1 0.0001
339 MUSCLE TWITCHING 2 0.0001
340 METASTASES TO LUNG 1 0.0001
341 CAESAREAN SECTION 1 0.0001
342 BURNING SENSATION 6 0.0001
343 DYSPHONIA 5 0.0001
344 PALPITATIONS 10 0.0001
345 HEADACHE 53 0.0001
346 MUSCLE RIGIDITY 1 0.0001
347 URTICARIA 14 0.0001
348 NOCTURIA 1 0.0001
349 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
350 GENERALISED OEDEMA 1 0.0001
351 INJECTION SITE DISCOLOURATION 1 0.0001
352 SYNCOPE 8 0.0001
353 POISONING 1 0.0001
354 UNEVALUABLE EVENT 6 0.0001
355 HYPERHIDROSIS 10 0.0001
356 NODULE 1 0.0001
357 JOINT STIFFNESS 2 0.0001
358 DERMATITIS ATOPIC 4 0.0001
359 DISORIENTATION 3 0.0001
360 QUALITY OF LIFE DECREASED 1 0.0001
361 IMPAIRED GASTRIC EMPTYING 1 0.0001
362 MIGRAINE 7 0.0001
363 MALAISE 32 0.0001
364 POLLAKIURIA 3 0.0001
365 ATRIAL FIBRILLATION 7 0.0001
366 NECK PAIN 4 0.0001
367 CARPAL TUNNEL SYNDROME 1 0.0001
368 HYPONATRAEMIA 4 0.0001
369 SEASONAL ALLERGY 1 0.0001
370 LOSS OF CONSCIOUSNESS 9 0.0001
371 DIZZINESS 35 0.0001
372 RED BLOOD CELL COUNT DECREASED 2 0.0001
373 PARAESTHESIA 11 0.0001
374 RECTAL HAEMORRHAGE 3 0.0001
375 PARAESTHESIA ORAL 1 0.0001
376 VAGINAL HAEMORRHAGE 3 0.0001
377 HYPOKINESIA 1 0.0001
378 DYSSTASIA 2 0.0001
379 SKIN HAEMORRHAGE 1 0.0001
380 PULMONARY MASS 1 0.0001
381 COLITIS ULCERATIVE 3 0.0001
382 HYPOAESTHESIA ORAL 1 0.0001
383 OSTEOPENIA 1 0.0001
384 ABDOMINAL DISCOMFORT 11 0.0001
385 HIP ARTHROPLASTY 1 0.0001
386 THYROID DISORDER 1 0.0001
387 SWOLLEN TONGUE 2 0.0001
388 HALLUCINATION, AUDITORY 1 0.0001
389 STAPHYLOCOCCAL INFECTION 2 0.0001
390 EXPIRED PRODUCT ADMINISTERED 2 0.0001
391 HYPOAESTHESIA 9 0.0001
392 CONSTIPATION 13 0.0001
393 CELLULITIS 3 0.0001
394 FEELING ABNORMAL 14 0.0001
395 SCAR 1 0.0001
396 MUSCULOSKELETAL DISCOMFORT 1 0.0001
397 PAIN IN EXTREMITY 17 0.0001
398 NEOPLASM PROGRESSION 2 0.0001
399 ORTHOSTATIC HYPOTENSION 1 0.0001
400 MUSCULOSKELETAL PAIN 3 0.0001
401 HEAD DISCOMFORT 1 0.0001
402 GALLBLADDER DISORDER 1 0.0001
403 ADVERSE DRUG REACTION 5 0.0001
404 BLOOD GLUCOSE ABNORMAL 1 0.0001
405 CHEST PAIN 10 0.0001
406 EYE SWELLING 2 0.0001
407 HEPATIC STEATOSIS 1 0.0001
408 MIDDLE INSOMNIA 1 0.0001
409 ERYTHEMA 11 0.0001
410 BLISTER 3 0.0001
411 DYSARTHRIA 2 0.0001
412 CHRONIC KIDNEY DISEASE 4 0.0001
413 GASTRIC ULCER 1 0.0001
414 FEELING JITTERY 1 0.0001
415 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
416 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
417 ACUTE RESPIRATORY FAILURE 1 0.0001
418 GLAUCOMA 1 0.0001
419 HERNIA 1 0.0001
420 PRESCRIBED OVERDOSE 1 0.0001
421 ORAL HERPES 1 0.0001
422 NASAL CONGESTION 3 0.0001
423 DISABILITY 1 0.0001
424 BLOOD PRESSURE ABNORMAL 1 0.0001
425 UPPER LIMB FRACTURE 1 0.0001
426 PRESCRIBED UNDERDOSE 1 0.0001
427 PRODUCT PHYSICAL ISSUE 1 0.0000
428 TASTE DISORDER 1 0.0000
429 FEELING HOT 3 0.0000
430 MOUTH ULCERATION 1 0.0000
431 EATING DISORDER 1 0.0000
432 IRRITABLE BOWEL SYNDROME 1 0.0000
433 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
434 INSOMNIA 12 0.0000
435 GASTROINTESTINAL DISORDER 4 0.0000
436 MUSCULAR WEAKNESS 5 0.0000
437 SKIN DISCOLOURATION 2 0.0000
438 SHOCK 1 0.0000
439 SEIZURE 5 0.0000
440 BACK PAIN 10 0.0000
441 SLEEP DISORDER 3 0.0000
442 ANXIETY 12 0.0000
443 RASH ERYTHEMATOUS 2 0.0000
444 BLOOD PRESSURE FLUCTUATION 1 0.0000
445 CONTUSION 4 0.0000
446 JOINT SWELLING 5 0.0000
447 NEURALGIA 1 0.0000
448 URINARY TRACT INFECTION 7 0.0000
449 INJECTION SITE URTICARIA 1 0.0000
450 BRONCHITIS 3 0.0000
451 HEART RATE INCREASED 4 0.0000
452 WEIGHT INCREASED 9 0.0000
453 AGEUSIA 1 0.0000
454 HOT FLUSH 3 0.0000
455 GASTRIC CANCER 1 0.0000
456 HAEMATEMESIS 1 0.0000
457 DIABETES MELLITUS 3 0.0000
458 FLUSHING 4 0.0000
459 INJECTION SITE SWELLING 3 0.0000
460 HYPOPHAGIA 1 0.0000
461 CHEST DISCOMFORT 4 0.0000
462 ERECTILE DYSFUNCTION 1 0.0000
463 INFLAMMATION 2 0.0000
464 RASH GENERALISED 1 0.0000
465 DIPLOPIA 1 0.0000
466 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
467 NERVOUSNESS 2 0.0000
468 ECZEMA 2 0.0000
469 ANHEDONIA 1 0.0000
470 EAR INFECTION 1 0.0000
471 PAIN 23 0.0000
472 FEAR 1 0.0000
473 BLOOD GLUCOSE INCREASED 7 0.0000
474 BLOOD BILIRUBIN INCREASED 1 0.0000
475 THROAT TIGHTNESS 1 0.0000
476 RASH PRURITIC 2 0.0000
477 PALLOR 1 0.0000
478 SKIN LESION 1 0.0000
479 HAEMATOCHEZIA 2 0.0000
480 ANAPHYLACTIC REACTION 2 0.0000
481 RENAL IMPAIRMENT 3 0.0000
482 EYE PAIN 2 0.0000
483 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
484 HERPES ZOSTER 2 0.0000
485 LETHARGY 2 0.0000
486 DECREASED APPETITE 8 0.0000
487 ASCITES 1 0.0000
488 LABORATORY TEST ABNORMAL 1 0.0000
489 PSYCHOTIC DISORDER 1 0.0000
490 TACHYCARDIA 3 0.0000
491 URINARY INCONTINENCE 1 0.0000
492 APHASIA 1 0.0000
493 HYPERTENSION 7 0.0000
494 VERTIGO 2 0.0000
495 LIMB DISCOMFORT 1 0.0000
496 SWELLING 3 0.0000
497 DYSPHAGIA 3 0.0000
498 HEAD INJURY 1 0.0000
499 CYSTITIS 1 0.0000
500 GAIT DISTURBANCE 6 0.0000
501 HYPOTHYROIDISM 1 0.0000
502 HIP FRACTURE 1 0.0000
503 DRUG INTOLERANCE 3 0.0000
504 DEEP VEIN THROMBOSIS 2 0.0000
505 BLOOD CREATININE INCREASED 2 0.0000
506 PSORIASIS 4 0.0000
507 ALOPECIA 6 0.0000
508 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
509 BLOOD PRESSURE DECREASED 2 0.0000
510 LIP SWELLING 1 0.0000
511 SKIN DISORDER 1 0.0000
512 EYE PRURITUS 1 0.0000
513 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
514 PRODUCT QUALITY ISSUE 4 0.0000
515 MYALGIA 5 0.0000
516 DELIRIUM 1 0.0000
517 WEIGHT DECREASED 8 0.0000
518 PRURITUS 11 0.0000
519 RASH MACULAR 1 0.0000
520 COVID-19 5 0.0000
521 HEART RATE DECREASED 1 0.0000
522 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
523 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
524 THERAPY INTERRUPTED 2 0.0000
525 CRYING 1 0.0000
526 PANIC ATTACK 1 0.0000
527 PRODUCT DOSE OMISSION ISSUE 8 0.0000
528 DYSURIA 1 0.0000
529 INJECTION SITE MASS 1 0.0000
530 HYPERSENSITIVITY 5 0.0000
531 DYSGEUSIA 2 0.0000
532 INFLUENZA 3 0.0000
533 HEPATIC FUNCTION ABNORMAL 1 0.0000
534 ASTHENIA 10 0.0000
535 ASTHMA 3 0.0000
536 PERIPHERAL SWELLING 4 0.0000
537 RASH 11 0.0000
538 PSORIATIC ARTHROPATHY 1 0.0000
539 BLINDNESS 1 0.0000
540 FATIGUE 19 0.0000
541 SKIN EXFOLIATION 2 0.0000
542 OSTEOARTHRITIS 1 0.0000
543 DEVICE DISLOCATION 1 0.0000
544 OFF LABEL USE 20 0.0000
545 PULMONARY OEDEMA 1 0.0000
546 THERAPY NON-RESPONDER 1 0.0000
547 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
548 VISION BLURRED 3 0.0000
549 TINNITUS 1 0.0000
550 ARTHRALGIA 9 0.0000
551 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
552 COGNITIVE DISORDER 1 0.0000
553 COUGH 6 0.0000
554 OCULAR HYPERAEMIA 1 0.0000
555 RENAL CANCER 1 0.0000
556 LUNG DISORDER 1 0.0000
557 AGGRESSION 1 0.0000
558 FLUID RETENTION 1 0.0000
559 ACUTE KIDNEY INJURY 3 0.0000
560 SPEECH DISORDER 1 0.0000
561 CONFUSIONAL STATE 3 0.0000
562 PNEUMONIA 6 0.0000
563 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
564 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
565 OXYGEN SATURATION DECREASED 1 0.0000
566 DYSPNOEA 10 0.0000
567 PRODUCT SUBSTITUTION ISSUE 1 0.0000
568 PYREXIA 6 0.0000
569 BLADDER CANCER 1 0.0000
570 WHEEZING 1 0.0000
571 IRRITABILITY 1 0.0000
572 EMOTIONAL DISTRESS 2 0.0000
573 STOMATITIS 1 0.0000
574 ILL-DEFINED DISORDER 1 0.0000
575 INJECTION SITE PAIN 5 0.0000
576 VISUAL IMPAIRMENT 2 0.0000
577 EXPOSURE DURING PREGNANCY 1 0.0000
578 RHINORRHOEA 1 0.0000
579 AMNESIA 1 0.0000
580 DRY SKIN 2 0.0000
581 HYPOTENSION 3 0.0000
582 HEPATIC ENZYME INCREASED 1 0.0000
583 INJURY 1 0.0000
584 MOBILITY DECREASED 1 0.0000
585 EPISTAXIS 1 0.0000
586 DEPRESSION 3 0.0000
587 CONDITION AGGRAVATED 4 0.0000
588 INJECTION SITE BRUISING 1 0.0000
589 CARDIAC FAILURE CONGESTIVE 1 0.0000
590 PROSTATE CANCER 1 0.0000
591 DRY MOUTH 1 0.0000
592 CARDIAC ARREST 1 0.0000
593 TREATMENT FAILURE 1 0.0000
594 FALL 4 0.0000
595 MUSCULOSKELETAL STIFFNESS 1 0.0000
596 DRUG WITHDRAWAL SYNDROME 1 0.0000
597 ADVERSE EVENT 1 0.0000
598 OROPHARYNGEAL PAIN 1 0.0000
599 BREAST CANCER 1 0.0000
600 NEUROPATHY PERIPHERAL 1 0.0000
601 ANAEMIA 2 0.0000
602 SOMNOLENCE 2 0.0000
603 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
604 SINUSITIS 1 0.0000
605 OEDEMA PERIPHERAL 1 0.0000
606 INJECTION SITE ERYTHEMA 1 0.0000
607 RENAL FAILURE 1 0.0000
608 MEMORY IMPAIRMENT 1 0.0000
609 INFECTION 1 0.0000
610 HOSPITALISATION 1 0.0000
611 TOXICITY TO VARIOUS AGENTS 1 0.0000
612 CEREBROVASCULAR ACCIDENT 1 0.0000
613 NO ADVERSE EVENT 1 0.0000
614 NASOPHARYNGITIS 1 0.0000
615 DEATH 1 0.0000